Search Results - "Reagan, Jane E"

Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in vivo and in vitro by Horiuchi, Noboru, Caulfield, Michael P., Fisher, John E., Goldman, Mark E., McKee, Roberta L., Reagan, Jane E., Levy, Jay J., Nutt, Ruth F., Rodan, Sevgi B., Schofield, Timothy L., Clemens, Thomas L., Rosenblatt, Michael

“…One mechanism considered responsible for the hypercalcemia that frequently accompanies malignancy is secretion by the tumor of a circulating factor that alters…”
Get full text

Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial by Lindsay, Robert, Cosman, Felicia, Lobo, Rogerio A, Walsh, Brian W, Harris, Steven T, Reagan, Jane E, Liss, Charles L, Melton, Mary E, Byrnes, Christine A

“…ABSTRACTAlendronate and estrogen are effective therapies for postmenopausal osteoporosis, but their efficacy and safety as combined therapy are unknown. The…”
Get full text

Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists by Chorev, Michael, Goldman, Mark E, McKee, Roberta L, Roubini, Eliahu, Levy, Jay J, Gay, C. Thomas, Reagan, Jane E, Fisher, John E, Caporale, Lynn H

“…Truncated N-terminal fragments of parathyroid hormone (PTH), [Tyr34]bovine PTH(7-34)NH2, and parathyroid hormone related protein (PTHrP), PTHrP(7-34)NH2,…”
Get full text

Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial1 by Lindsay, Robert, Cosman, Felicia, Lobo, Rogerio A, Walsh, Brian W, Harris, Steven T, Reagan, Jane E, Liss, Charles L, Melton, Mary E, Byrnes, Christine A

“…Alendronate and estrogen are effective therapies for postmenopausal osteoporosis, but their efficacy and safety as combined therapy are unknown. The objective…”
Get full text

Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial 1 by Lindsay, Robert, Cosman, Felicia, Lobo, Rogerio A., Walsh, Brian W., Harris, Steven T., Reagan, Jane E., Liss, Charles L., Melton, Mary E., Byrnes, Christine A.

Get full text

Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis by Simon, Thomas J., Roberts, Willian G., Berlin, Roger G., Hayden, Lisa J., Berman, Rayanne S., Reagan, Jane E.

“…Control of esophageal acid exposure is important in treating patients with gastroesophageal reflux disease (GERD). After complete healing of esophagitis, most…”
Get full text

A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2 by Goldman, M E, McKee, R L, Caulfield, M P, Reagan, J E, Levy, J J, Gay, C T, DeHaven, P A, Rosenblatt, M, Chorev, M

“…Based upon N-terminal parathyroid hormone (PTH) analog structure-activity relationship studies, position 12 was found to possess a wide structural latitude and…”
Get more information

Evaluation of novel parathyroid hormone analogs using a bovine renal membrane receptor binding assay by Goldman, M E, Chorev, M, Reagan, J E, Nutt, R F, Levy, J J, Rosenblatt, M

“…A PTH membrane receptor binding assay based on a stable hormone analog radioligand was refined and used with bovine renal cortical membranes to evaluate PTH…”
Get more information

Biological activity of parathyroid hormone antagonists substituted at position 13 by Chorev, M, Roubini, E, McKee, R L, Gibbons, S W, Reagan, J E, Goldman, M E, Caulfield, M P, Rosenblatt, M

“…Lysine occupies position 13 in the parathyroid hormone (PTH) antagonist, [Nle8,18,Tyr34]bPTH(7-34)NH2. Acylation of the epsilon-amino group in lysine 13 by a…”
Get more information

Fasting and L-364,718 prevent cholecystokinin-induced elevations of plasma insulin levels by Reagan, J E, Robinson, J L, Lotti, V J, Goldman, M E

“…Sulfated CCK-8 but not non-sulfated CCK-8 induced a dose-dependent increase in plasma insulin levels in fed mice. In fasted mice, however, the CCK peptides…”
Get more information

Avian (chicken) parathyroid hormone: synthesis and comparative biological evaluation of the 1-34 fragment by Caulfield, M P, Levy, J J, McKee, R L, Goldman, M E, DeHaven, P A, Reagan, J E, Heaney, L, Nutt, R F, Winquist, R J, Russell, J

“…The full-length amino acid sequence of the avian (chicken) form of parathyroid hormone (cPTH) has recently been elucidated. We have chemically synthesized,…”
Get more information

A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology by Rosenblatt, M, Caulfield, M P, Fisher, J E, Horiuchi, N, Mckee, R L, Rodan, S B, Thiede, M A, Thompson, D D, Seedor, J G, Nutt, R E

“…This investigation addresses a theoretical concept of tumor pathogenesis proposed over 40 years ago, namely that malignancy-associated hypercalcemia can result…”
Get more information

Effects of hydrophobic substitutions at position 18 on the potency of parathyroid hormone antagonists by Chorev, M, Roubini, E, Goldman, M E, McKee, R L, Gibbons, S W, Reagan, J E, Caulfield, M P, Rosenblatt, M

“…Position 18 in a parathyroid hormone (PTH) antagonist, [Nle8,18,Tyr34]bPTH(7-34)NH2 (ii), was shown to tolerate substitutions by a range of amino acids with…”
Get more information